Nuha Ibrahim, MD
Nephrology · Los Angeles, CANPI 1043519341
Payments from drug & device makers
Across 17 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ANI Pharmaceuticals, Inc.$130
- Ardelyx, Inc.$63
- Akebia Therapeutics Inc$51
- OPKO Pharmaceuticals, LLC$31
- Novo Nordisk$28
- Calliditas Therapeutics US Inc.$25
- plus $77 from 4 others
What the payments were for
- Food & beverage$406100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 4 | $130 |
| Ardelyx, Inc. | 3 | $63 |
| Akebia Therapeutics Inc | 2 | $51 |
| OPKO Pharmaceuticals, LLC | 2 | $31 |
| Novo Nordisk | 1 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
| Amgen | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Bayer | 1 | $16 |
How this compares
$406 in reported general payments places this provider in the 30th percentile of 1,341 nephrology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 12 | $6,501 |
| ProsolParenteral Amino Acid 20% No.1 | 34 | $4,473 |
| Chlorthalidone | 25 | $460 |
| Amlodipine Besylate | 37 | $311 |
| Losartan Potassium | 13 | $159 |
| Lisinopril | 13 | $65 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Los Angeles
- Anjay RastogiLos Angeles$6.3M
- Mohamed El-ShahawyLos Angeles$4.4M
- Suphamai BunnapradistLos Angeles$1.7M
- Victor CarabelloLos Angeles$1.4M
- John SimLos Angeles$1.3M
- Tariq ShahLos Angeles$1.2M
- Michael LevineLos Angeles$867K
- Aamir JamalSan Dimas$5.5M
- Kalpesh PatelCalabasas$3.6M
- Jehad HaggiagiMission Hills$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.